Evidence map›Paper›PMID 37868272›Full record

ArticleFrontiers in pediatrics2023

Genetic risk variants for childhood nephrotic syndrome and corticosteroid response.

Rachel K Cason, Eileen Chambers, Tiffany Tu, Megan Chryst-Stangl, Kinsie Huggins, Brandon M Lane, Alejandro Ochoa, Annette M Jackson, Rasheed A Gbadegesin

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Rachel K Cason *Department of Pediatrics, Division of Nephrology, Duke University Medical Center, Durham, NC, United States.
Eileen Chambers *Department of Pediatrics, Division of Nephrology, Duke University Medical Center, Durham, NC, United States.
Tiffany TuComputational Biology and Bioinformatics Program, Duke Center for Statistical Genetics and Genomics, and Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, United States.
Megan Chryst-StanglDepartment of Pediatrics, Division of Nephrology, Duke University Medical Center, Durham, NC, United States.
Kinsie HugginsDepartment of Pediatrics, Division of Nephrology, Duke University Medical Center, Durham, NC, United States.
Brandon M LaneDepartment of Pediatrics, Division of Nephrology, Duke University Medical Center, Durham, NC, United States.
Alejandro OchoaComputational Biology and Bioinformatics Program, Duke Center for Statistical Genetics and Genomics, and Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, United States.
Annette M JacksonDepartment of Surgery, Duke University Medical Center, Durham, NC, United States.
Rasheed A GbadegesinDepartment of Pediatrics, Division of Nephrology, Duke University Medical Center, Durham, NC, United States.
Duke Medical Center · USDuke University · US

Funding

Defining the Landscape of HLA Risk Alleles in Primary Nephrotic Syndrome and Post Kidney Transplant RecurrenceU01AI152585 · NIAID · DUKE UNIVERSITY · PI GBADEGESIN, RASHEED ADEBAYO, JACKSON, ANNETTE MARIE · 2020 to 2024
$3.7M
Gene Discovery in Autosomal Dominant Focal Segmental GlomerulosclerosisR01DK094987 · NIDDK · DUKE UNIVERSITY · PI GBADEGESIN, RASHEED ADEBAYO · 2012 to 2016
$2.5M
NIAID NIH HHS U01 AI152585NIDDK NIH HHS R01 DK094987
6 · The paper itself

Abstract

Introduction: The etiology of most cases of nephrotic syndrome (NS) remains unknown, therefore patients are phenotypically categorized based on response to corticosteroid therapy as steroid sensitive NS (SSNS), or steroid resistant NS (SRNS). Genetic risk factors have been identified for SSNS from unbiased genome-wide association studies (GWAS), however it is unclear if these loci are disease risk loci in other forms of NS such as SRNS. Additionally, it remains unknown if these risk loci are associated with response to therapy. Thus, we investigated the association between SSNS risk loci and therapy response in a large, multi-race cohort of children along the entire spectrum of childhood-onset NS. Methods: We enrolled 1,000 patients with childhood-onset NS comprised of SSNS and SRNS. Genotyping was done using TaqMan and Direct Sanger Sequencing for 9 previously reported childhood SSNS risk loci. We compared the allele frequencies (AF) and variant burden between NS vs. controls and SRNS vs. SSNS. Results: All 9 risk loci were associated with NS compared with healthy controls ( Conclusion: Our study showed that genetic risk loci for childhood SSNS are associated with pattern of therapy response, may help predict disease outcome, and set the stage for individualized treatment of NS.

Indexed as

geneticsnephrotic syndromerisk factorsSRNSSSNS

Identifiers

PMID37868272
PMCPMC10588181
OpenAlexW4387407545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.